RGEN - Repligen Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue104,54183,53763,548
Cost of Revenue47,11735,25128,022
Gross Profit57,42448,28635,526
Operating Expenses
Research Development7,3555,7405,609
Selling General and Administrative34,09528,78219,226
Non Recurring---
Total Operating Expenses---
Operating Income or Loss15,97413,76410,691
Income from Continuing Operations
Total Other Income/Expenses Net-514-309497
Earnings Before Interest and Taxes15,46013,45511,188
Interest Expense3,7683250
Income Before Tax11,69213,42311,138
Income Tax Expense114,0782,968
Minority Interest---
Net Income From Continuing Ops11,6819,3458,170
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income11,6819,3458,170
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares11,6819,3458,170